A critical breakthrough in cancer research is occurring with the use of mini-antibodies to re-engage damaged p53. This essential malignant inhibitor protein is frequently disabled in many kinds of malignancies, https://bookmarkbirth.com/story22669304/mini-antibodies-revive-the-p53-protein-the-promising-approach-for-cancer-therapy